Search filters

List of works by Sandra P D'Angelo

A Phase I Study of Binimetinib (MEK162) Combined with Pexidartinib (PLX3397) in Patients with Advanced Gastrointestinal Stromal Tumor

scientific article published on 18 June 2019

A Phase Ib/II Study of Gemcitabine and Docetaxel in Combination With Pazopanib for the Neoadjuvant Treatment of Soft Tissue Sarcomas

scientific article

A case series of dose-limiting peripheral edema observed in patients treated with pemetrexed

scientific article

A phase 2 study of ontuxizumab, a monoclonal antibody targeting endosialin, in metastatic melanoma

scientific article published on 11 November 2017

A phase Ib study of BGJ398, a pan-FGFR kinase inhibitor in combination with imatinib in patients with advanced gastrointestinal stromal tumor

scientific article published on 13 August 2018

Abstract PR012: Targeted sequencing of 2,138 bone and soft tissue sarcomas reveals commonly altered pathways, subtype-independent genetic clusters, and potential therapeutic targets

scientific article published in 2022

Analysis of the Chemotherapy-Free Interval following Image-Guided Ablation in Sarcoma Patients

scientific article published on 14 February 2020

Antitumor Activity Associated with Prolonged Persistence of Adoptively Transferred NY-ESO-1 c259T Cells in Synovial Sarcoma

scientific article published on 11 June 2018

Associations between mutations and histologic patterns of mucin in lung adenocarcinoma: invasive mucinous pattern and extracellular mucin are associated with KRAS mutation

scientific article

Autoimmune Bullous Skin Disorders with Immune Checkpoint Inhibitors Targeting PD-1 and PD-L1.

scientific article published on 29 February 2016

Avelumab Immunotherapy: Management of Adverse Events Associated With New Treatment for Merkel Cell Carcinoma

scientific article published on 01 February 2019

Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial

scientific article published on September 2016

Avelumab in patients with previously treated metastatic Merkel cell carcinoma: long-term data and biomarker analyses from the single-arm phase 2 JAVELIN Merkel 200 trial

scientific article published on 01 May 2020

Clinical activity of ipilimumab for metastatic uveal melanoma: a retrospective review of the Dana-Farber Cancer Institute, Massachusetts General Hospital, Memorial Sloan-Kettering Cancer Center, and University Hospital of Lausanne experience

scientific article published on 02 August 2013

Clinical, genomic, and transcriptomic correlates of response to immune checkpoint blockade-based therapy in a cohort of patients with angiosarcoma treated at a single center

scientific article published on 01 April 2022

Combined KIT and CTLA-4 Blockade in Patients with Refractory GIST and Other Advanced Sarcomas: A Phase Ib Study of Dasatinib plus Ipilimumab

scientific article published on 22 December 2016

Corrigendum to "Sarcoma Immunotherapy: Past Approaches and Future Directions".

scientific article published on 9 June 2015

Cytokine release syndrome after radiation therapy: case report and review of the literature

scientific article published on 3 January 2018

Distinct clinical course of EGFR-mutant resected lung cancers: results of testing of 1118 surgical specimens and effects of adjuvant gefitinib and erlotinib

scientific article published in December 2012

Driver mutations determine survival in smokers and never‐smokers with stage IIIB/IV lung adenocarcinomas ⬇️

scientific article published on May 17, 2012

Early objective response to avelumab treatment is associated with improved overall survival in patients with metastatic Merkel cell carcinoma

scholarly article by Sandra P D'Angelo et al published April 2019 in Cancer Immunology, Immunotherapy

Efficacy and Safety of First-line Avelumab Treatment in Patients With Stage IV Metastatic Merkel Cell Carcinoma: A Preplanned Interim Analysis of a Clinical Trial

scientific article published on 22 March 2018

Efficacy and Safety of Nivolumab Alone or in Combination With Ipilimumab in Patients With Mucosal Melanoma: A Pooled Analysis

scientific article published on 7 November 2016

Efficacy and immune-related adverse event associations in avelumab-treated patients

scientific article published on 01 November 2020

HLA Genotyping in Synovial Sarcoma: Identifying HLA-A*02 and its Association with Clinical Outcome

scientific article published on 14 August 2020

Health-related quality of life trajectory of treatment-naive patients with Merkel cell carcinoma receiving avelumab

scientific article published on 17 September 2020

High-risk features in radiation-associated breast angiosarcomas

scientific article published on 08 October 2013

Immune-Related Adverse Events, Need for Systemic Immunosuppression, and Effects on Survival and Time to Treatment Failure in Patients With Melanoma Treated With Ipilimumab at Memorial Sloan Kettering Cancer Center

scientific article published on 17 August 2015

Impact of surgery, radiation and systemic therapy on the outcomes of patients with dendritic cell and histiocytic sarcomas

scientific article published on 19 August 2015

Impact on disease-free survival of adjuvant erlotinib or gefitinib in patients with resected lung adenocarcinomas that harbor EGFR mutations

scientific article published on March 2011

Incidence of EGFR exon 19 deletions and L858R in tumor specimens from men and cigarette smokers with lung adenocarcinomas

scientific article published on 11 April 2011

Ipilimumab for patients with advanced mucosal melanoma

scientific article

Is Repeat Pulmonary Metastasectomy Indicated for Soft Tissue Sarcoma?

scientific article published on 24 October 2017

LBA3_PRA PHASE 3 RANDOMIZED, OPEN-LABEL STUDY OF NIVOLUMAB (ANTI-PD-1; BMS-936558; ONO-4538) VERSUS INVESTIGATOR'S CHOICE CHEMOTHERAPY (ICC) IN PATIENTS WITH ADVANCED MELANOMA AFTER PRIOR ANTI-CTLA-4 THERAPY

Langerhans-type dendritic cells electroporated with TRP-2 mRNA stimulate cellular immunity against melanoma: Results of a phase I vaccine trial

scientific article published on 21 September 2017

Long-term Follow-up and Patterns of Response, Progression, and Hyperprogression in Patients after PD-1 Blockade in Advanced Sarcoma

scientific article published on 01 March 2022

Molecular epidemiology of EGFR and KRAS mutations in 3,026 lung adenocarcinomas: higher susceptibility of women to smoking-related KRAS-mutant cancers

scientific article

Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial.

scientific article

Nivolumab with or without ipilimumab treatment for metastatic sarcoma (Alliance A091401): two open-label, non-comparative, randomised, phase 2 trials

scientific article published on 19 January 2018

Objective Response Rate Among Patients With Locally Advanced or Metastatic Sarcoma Treated With Talimogene Laherparepvec in Combination With Pembrolizumab: A Phase 2 Clinical Trial

scientific article published on 23 January 2020

Optimizing engineered TCR T cell therapy for synovial sarcoma

scientific article published on 4 November 2015

Outcomes of Systemic Therapy for Patients with Metastatic Angiosarcoma

scientific article published on 3 June 2015

Overall Survival and Response to Systemic Therapy in Metastatic Extrauterine Leiomyosarcoma

scientific article published on 29 May 2016

Overall Survival in Patients With Advanced Melanoma Who Received Nivolumab Versus Investigator's Choice Chemotherapy in CheckMate 037: A Randomized, Controlled, Open-Label Phase III Trial.

scientific article

Patient Experiences with Avelumab in Treatment-Naïve Metastatic Merkel Cell Carcinoma: Longitudinal Qualitative Interview Findings from JAVELIN Merkel 200, a Registrational Clinical Trial

scientific article published on 30 May 2020

Patient perspectives on ipilimumab across the melanoma treatment trajectory

scientific article

Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial

scientific article published on 4 October 2017

Phase IB Study of Selinexor, a First-in-Class Inhibitor of Nuclear Export, in Patients With Advanced Refractory Bone or Soft Tissue Sarcoma

scientific article

Phase II Trial of Gemcitabine and Docetaxel with Bevacizumab in Soft Tissue Sarcoma.

scientific article published on 14 May 2015

Phase II study of MLN8237 (Alisertib) in advanced/metastatic sarcoma

scientific article published on 8 August 2016

Phase II study of the GI-4000 KRAS vaccine after curative therapy in patients with stage I-III lung adenocarcinoma harboring a KRAS G12C, G12D, or G12V mutation

scientific article published on 21 June 2014

Phase II trial of the CDK4 inhibitor PD0332991 in patients with advanced CDK4-amplified well-differentiated or dedifferentiated liposarcoma.

scientific article

Prevalence and Preliminary Validation of Screening Criteria to Identify Carriers of Germline BAP1 Mutations

scientific article published on 16 July 2019

Prevalence of tumor-infiltrating lymphocytes and PD-L1 expression in the soft tissue sarcoma microenvironment

scientific article

Progression-Free Survival Among Patients With Well-Differentiated or Dedifferentiated Liposarcoma Treated With CDK4 Inhibitor Palbociclib: A Phase 2 Clinical Trial.

scientific article published on 28 April 2016

Pulmonary metastasectomy with therapeutic intent for soft-tissue sarcoma

scientific article published on 21 March 2017

Rapid eradication of a bulky melanoma mass with one dose of immunotherapy

scientific article published on 20 April 2015

Recurrent CIC Gene Abnormalities in Angiosarcomas: A Molecular Study of 120 Cases With Concurrent Investigation of PLCG1, KDR, MYC, and FLT4 Gene Alterations.

scientific article published on 5 January 2016

Reflex testing of resected stage I through III lung adenocarcinomas for EGFR and KRAS mutation: report on initial experience and clinical utility at a single center.

scientific article

Reply to A. Indini et al

scientific article published on 19 January 2016

Sarcoma immunotherapy: past approaches and future directions

scientific article published on 20 March 2014

Systemic and local immunity following adoptive transfer of NY-ESO-1 SPEAR T cells in synovial sarcoma

scientific article published on 24 October 2019

Tumor mutational load predicts survival after immunotherapy across multiple cancer types

scientific article published on 14 January 2019

Updated efficacy of avelumab in patients with previously treated metastatic Merkel cell carcinoma after ≥1 year of follow-up: JAVELIN Merkel 200, a phase 2 clinical trial

scientific article published on 19 January 2018

Paulina is supported by:

About Paulina

Help